<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05069844</url>
  </required_header>
  <id_info>
    <org_study_id>AP2106-50108</org_study_id>
    <nct_id>NCT05069844</nct_id>
  </id_info>
  <brief_title>Preoperative Gum Chewing for Different Durations to Prevent Sore Throat After Endotracheal Intubation</brief_title>
  <official_title>Preoperative Gum Chewing for Different Durations to Prevent Sore Throat After Endotracheal Intubation: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahmed Salah Ahmed Abd Elgalil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Egypt</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the effect preoperative chewing gums for 2 or 4 minutes on&#xD;
      postoperative sore throat after general anesthesia using an endotracheal tube.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pharmacological measures for attenuating postoperative sore throat (POST) include inhalation&#xD;
      of beclomethasone or fluticasone propionate; gargling with azulene sulfonate, aspirin, or&#xD;
      ketamine: gargling or spraying benzydamine hydrochloride; intravenous (IV) dexamethasone;&#xD;
      oral clonidine; topical or systemic lidocaine; and ingestion of strepsils tablets. Each of&#xD;
      these approaches has limitations and variable success rates; thus, no approach has become&#xD;
      established in routine clinical use. In the past decade, studies have shown that xylitol in&#xD;
      chewing gum may inhibit the growth, metabolism, and polysaccharide production of&#xD;
      Streptococcus mutans, which accounts for the highest proportion of the natural flora in the&#xD;
      oral cavity. Subsequent biofilm formation reduction may lead to some reduction in the number&#xD;
      of bacteria. Furthermore, chewing gum can promote salivary gland secretion, resulting in&#xD;
      lubrication and cleansing of the oral cavity. which may decrease postoperative sore throat.&#xD;
&#xD;
      Patients included in the study will be divided into 3 groups; the gum group2 (group G2), the&#xD;
      gum group4 (group G4) and the control group (group C) by a computer-generated random number&#xD;
      table before surgery. In the preoperative waiting area before transfer to the operating room,&#xD;
      patients in group G2 will chew 1 piece of herbal sugar-free for 2 minutes and then spat it&#xD;
      out, patients in group G4 will chew 1 piece of herbal sugar-free for 4 minutes and then spat&#xD;
      it out, group C will be asked to swallow 2 times only. After entering to the OR patients will&#xD;
      be routinely monitored with ECG, Pulse oximetry, and blood pressure then induction of&#xD;
      anesthesia will be done using Fentanyl 1 to 2 mcg per kg, propofol 1 to 3 mg per kg, and&#xD;
      atracurium 0.6 mg per kg. endotracheal tube size 7.5 will be inserted. volume-controlled&#xD;
      ventilation was initiated with a mixture of 50% oxygen and 50% air, a respiratory rate of 12&#xD;
      cyclesÂ·minute, an inspiratory-to-expiratory ratio (I:E) of 1:2 and an adjusted end-tidal CO2&#xD;
      maintained at approximately 35-40 mm Hg. Ondansetron (4 mg) and paracetamol 1g were injected&#xD;
      IV to prevent postoperative nausea, vomiting, and pain. Patients will be extubated after&#xD;
      being awake using minimal suction. Postoperative sore throat (POST) will be evaluated by the&#xD;
      numerical rating scale (NRS), which ranges from 0 to 10 points, with 0 indicating no pain,&#xD;
      1-3 indicating mild discomfort, 4-6 indicating moderate pain, and 7-10 indicating severe&#xD;
      pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients included in the study will be divided into 3 groups; the gum group2 (group G2), the gum group4 (group G4) and the control group (group C) by a computer-generated random number table before surgery.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of moderate/severe postoperative sore throat (POST) within 24 hours after surgery POST within 24 hours after surgery</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>The incidence of moderate/severe POST within 24 hours after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative sore throat (POST) numeric rating scale (NRS) scores 2, 6, and 24 hours after surgery</measure>
    <time_frame>24 hours Postoperative</time_frame>
    <description>POST will be evaluated by the numerical rating scale (NRS), which ranges from 0 to 10 points, with 0 indicating no pain, 1-3 indicating mild discomfort, 4-6 indicating moderate pain, and 7-10 indicating severe pain. The higher is worse.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Gum Chewing</condition>
  <condition>Sore Throat</condition>
  <condition>Endotracheal Intubation</condition>
  <condition>Randomized Controlled Trial</condition>
  <arm_group>
    <arm_group_label>Gum chewing for 2 minutes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will chew 1 piece of herbal sugar-free for 2 minutes and then spat it out.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gum chewing for 4 minutes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will chew 1 piece of herbal sugar-free for 4 minutes and then spat it out.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be asked to swallow 2 times only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Gum chewing for 2 minutes</intervention_name>
    <description>In the preoperative waiting area before transfer to the operating room, patients will chew 1 piece of herbal sugar-free for 2 minutes and then spat it out.</description>
    <arm_group_label>Gum chewing for 2 minutes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Gum chewing for 4 minutes</intervention_name>
    <description>In the preoperative waiting area before transfer to the operating room, patients will chew 1 piece of herbal sugar-free for 4 minutes and then spat it out.</description>
    <arm_group_label>Gum chewing for 4 minutes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Provision of signed and dated informed consent form&#xD;
&#xD;
          2. Stated willingness to comply with all study procedures and availability for the&#xD;
             duration of the study&#xD;
&#xD;
          3. Age 21-65 years&#xD;
&#xD;
          4. Females&#xD;
&#xD;
          5. American Society of Anesthesiologists (ASA) physical I-II&#xD;
&#xD;
          6. Scheduled for elective breast surgery&#xD;
&#xD;
          7. Under general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Chronic laryngitis&#xD;
&#xD;
          2. Chronic bronchitis&#xD;
&#xD;
          3. Asthma&#xD;
&#xD;
          4. Gastroesophageal reflux&#xD;
&#xD;
          5. Allergies to study drugs&#xD;
&#xD;
          6. Recent use of nonsteroidal anti-inflammatory drugs (NSAIDs)&#xD;
&#xD;
          7. A history of upper respiratory tract infection&#xD;
&#xD;
          8. Smoking and steroid therapy in the past week&#xD;
&#xD;
          9. Failure to communicate normally&#xD;
&#xD;
         10. Mallampati grade &gt;2&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Females</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Atef Badran, MD</last_name>
    <phone>+201001200155</phone>
    <email>irb@nci.cu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Cancer Institute - Egypt</name>
      <address>
        <city>Cairo</city>
        <zip>11561</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed S Abdelgalil, MD</last_name>
      <phone>00201098426689</phone>
      <email>ahmed.salah@nci.cu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 25, 2021</study_first_submitted>
  <study_first_submitted_qc>September 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Institute, Egypt</investigator_affiliation>
    <investigator_full_name>Ahmed Salah Ahmed Abd Elgalil</investigator_full_name>
    <investigator_title>Lecturer of Anesthesiology and Pain Management</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data will be available upon reasonable request from the corresponding author</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>One year after the end of the study</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

